Cost-effectiveness analysis of the genotyping-based treatment for ER+ breast cancer patients treated with tamoxifen

Additional Metadata
Keywords	Pharmacogenetics - Pharmacogenetic passport - Cost-effectiveness analysis - Breast cancer - Tamoxifen
Thesis Advisor	Birnie, E.
Persistent URL	hdl.handle.net/2105/59234
Series	Business Economics
Organisation	Erasmus School of Economics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Hendriks, J.M.H. (2021, August 26). Cost-effectiveness analysis of the genotyping-based treatment for ER+ breast cancer patients treated with tamoxifen. Business Economics. Retrieved from http://hdl.handle.net/2105/59234

Publication